1092392-85-2

Upstream product

• 1092393-99-1 2-[2-{[(4-methylphenyl)sulfonyl]imino}-5-(3-nitrophenoxy)pyridin-1(2H)-yl]acetamide 
• 1092394-00-7 4-methyl-N-[5-(3-nitrophenoxy)pyridin-2-yl]benzenesulfonamide 
• 1092394-58-5 N-[6-(3-nitrophenoxy)imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide 
• 1092394-56-3 6-(3-nitrophenoxy)imidazo[1,2-a]pyridin-2-amine 
• 1092393-98-0 5-(3-nitrophenoxy)pyridin-2-amine 
• 402-67-5 3-fluoro-1-nitrobenzene 
• 827028-99-9 5-(3-nitrophenoxy)pyridine-2-carboxylic acid 
• 228401-34-1 3-(5-methyl-3-pyridinyloxy)-1-nitrobenzene 
• 1121-78-4 5-Hydroxy-2-methylpyridine 
• 1092394-60-9 N-[6-(3-aminophenoxy)imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide 
• 1795-48-8 Isopropyl isocyanate 

Relevant academic research and scientific papers

HETEROBICYCLIC COMPOUNDS AS KINASE INHIBITORS

A compound represented by the formula (I): wherein Z1,Z2,Z3 and Z4 are the following combination, (Z1,Z2,Z3,Z4)=(CR4,N,CR5,C), (N,N,CR5,C), (N,C,CR5,N), (S,C,CR5,C) or (S,C,N,C); R1 and R2 are the same or different and each is (1) a hydrogen atom, (2) a halogen atom, (3) a group bonded via a carbon atom, (4) a group bonded via a nitrogen atom, (5) a group bonded via an oxygen atom or (6) a group bonded via a sulfur atom; R 3 is an amino optionally having substituent(s); R4 and R 5 are the same or different and each is (1) a hydrogen atom, (2) a halogen atom, (3) a group bonded via a carbon atom, (4) a group bonded via a nitrogen atom, (5) a group bonded via an oxygen atom or (6) a group bonded via a sulfur atom; R3 and R4 optionally form a ring optionally having substituent(s); and a group represented by the formula (A) is a cyclic group optionally having substituent(s), or a salt thereof